R&D >
Discovery platform  |
| |
 |
Monoclonal Antibody-mediated Biomarker Discovery
The innovative process created by BSI scientists, called monoclonal antibody proteomics combines several key technologies consisting of the chromatographic processing of human plasma, the high throughput generation of monoclonal antibodies (mAbs), and high throughput screening (HTS) to identify those antibodies which are suitable for further development for the production of microarrays and/or novel diagnostic products. The antibodies are furthermore used to identify the cognate antigen.
|
|
 |
|
|
|
top of page 
contact us
home .
contact us .
terms of use .
sitemap .
